STOCKHOLM, 27 February 2023 – Promore Pharma AB (publ) publishes its interim report for the forth quarter 2022 on 28 February 2023.
The day after, the 1 March at 10:00 CET, the company will host a webcast telephone conference with President and CEO Jonas Ekblom. After the presentation there will be a Q&A session. The conference call will be held in Swedish and can be accessed via computer, tablet, or telephone.
The number of attendees is limited, please register for the conference in advance on the following link:
The conference call will be recorded and made available on the company´s website after the call, and on Västra Hamnen Corporate Finance Youtube channel.